FIELD: chemistry; pharmaceuticals. SUBSTANCE: invention relates to activators of the synthesis of heat shock proteins. The following is disclosed: the use of a compound selected from the group of 9-(5-hydroxy-1H-indol-3-yl)-10-methylacridinium iodide, 4-(5-bromo-1H-indol-3-yl)-2-chloropyrimidine, 4-(5-bromo-1H-indol-3-yl)quinazoline and 3-(5-phenyl-1H-pyrrol-2-yl)quinoxalin-2(1H)-one to activate the synthesis of heat shock proteins, as well as compound 9-(5-hydroxy-1H-indol-3-yl)-10-methylacridinium iodide and 4-(5-bromo-1H-indol-3-yl)quinazoline as activators of heat shock protein synthesis. EFFECT: use of the invention makes it possible to effectively activate the synthesis of heat shock proteins. 3 cl, 8 dwg, 4 ex.